{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:49:19Z","timestamp":1770508159200,"version":"3.49.0"},"reference-count":20,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,5,13]],"date-time":"2008-05-13T00:00:00Z","timestamp":1210636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Disseminated aspergillosis in immunocompromised patients has a mortality rate of almost 100%. Despite the development of new antifungal agents, the outcome of disseminated aspergillosis has only improved slightly, particular in patients with central nervous system (CNS) involvement. The use of combination antifungal therapy might improve the dismal outcome of disseminated aspergillosis. We describe a critically ill adolescent with acute lymphoblastic leukemia who was successfully treated with voriconazole and caspofungin for disseminated aspergillosis with involvement of the lung, brain and thyroid gland. Pediatr Blood Cancer 2008;51:423\u2013426. \u00a9 2008 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/pbc.21601","type":"journal-article","created":{"date-parts":[[2008,5,13]],"date-time":"2008-05-13T18:46:28Z","timestamp":1210704388000},"page":"423-426","source":"Crossref","is-referenced-by-count":13,"title":["Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia"],"prefix":"10.1002","volume":"51","author":[{"given":"Annelies M.","family":"Zwitserloot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adilia","family":"Warris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis G.","family":"van't Hek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lya E.","family":"van Die","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelies M.C.","family":"Mavinkurve\u2010Groothuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,5,13]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702604"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.8.2564-2568.2002"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/318483"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0733"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/313445"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2007.01.013"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.1999.00496.x"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/323335"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-005-0239-3"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.2002.t01-2-02002.x"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.11.2339"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/377131"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2004.05.011"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/423381"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-7-28"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22348"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/423380"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6904-6-6"},{"key":"e_1_2_4_20_2","unstructured":"FDA.Antiviral Drugs Advisory Committee \u2013 Briefing Document for Voriconazole (Oral and Intravenous Formulations).http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/01\/briefing\/3792b2_01_Pfizer.pdf."},{"key":"e_1_2_4_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22863"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.21601","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.21601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T16:03:05Z","timestamp":1697644985000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.21601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,13]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1002\/pbc.21601"],"URL":"https:\/\/doi.org\/10.1002\/pbc.21601","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,13]]}}}